Phibro Animal Health | PAHC - Net Income

Stock Price
52.26
Daily Change
0.99 1.93%
Monthly
31.08%
Yearly
102.79%
Q1 Forecast
12.72

Phibro Animal Health reported $3.18M in Net Income for its fiscal quarter ending in December of 2024.





Net Income Change Date
Align Technology USD 135.76M 79.01M Dec/2025
ANI Pharmaceuticals USD 26.27M 18.13M Sep/2025
Assertio Holdings USD -2.92M 753K Sep/2024
Aurora Cannabis CAD -51.47M 36.26M Sep/2025
Bristol-Myers Squibb USD 1.09B 1.11B Dec/2025
Canopy Growth CAD -1.64M 39.89M Sep/2025
Corcept Therapeutics USD 19.67M 15.48M Sep/2025
Eli Lilly USD 6.64B 1.05B Dec/2025
Henry Schein USD 101M 15M Sep/2025
Idexx Laboratories USD 248.19M 26.42M Dec/2025
Knight Therapeutics CAD 85K 2.03M Sep/2024
Merck USD 2.96B 2.82B Dec/2025
Nektar Therapeutics USD -37.06M 15.31M Sep/2024
Pacira USD 5.43M 10.28M Sep/2025
Phibro Animal Health USD 3.18M 3.79M Dec/2024
Prestige Brands USD 46.7M 22.44M Dec/2025
Supernus Pharmaceuticals USD -45.12M 67.62M Sep/2025
Zoetis USD 603M 118M Dec/2025